Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates.

Authors: Ramadas AV,Gunesh S,Thomas GA,Williams GT,Hawthorne AB,
Address: Department of Gastroenterology, University Hospital of Wales Cardiff, UK.
Journal: Gut.


Publication: 2010 Sep;59(9):1200-6. doi: 10.1136/gut.2009.202101. Epub 2010 Jul 21.

abstract

INTRODUCTION:

Benefits of immunosuppressive therapy in Crohn's disease have been demonstrated in controlled trials; however, it is unclear whether these drugs alter the longer-term Natural history of this condition.

AIMS and METHODS:

To assess changes in disease outcomes in a population-based cohort of patients diagnosed in Cardiff from 1986 to 2003. Case notes from Crohn's disease incidence studies in Cardiff were reviewed retrospectively for disease characteristics and follow-up information on drug therapy, and the need for surgery for Crohn's disease. The study population was divided into three groups by year of diagnosis (Group A=1986-1991, Group B=1992-1997 and Group C=1998-2003).

RESULTS:

341 patients were included. Kaplan-Meier (KM) analysis showed increasing use of immunosuppressants over time. At 5 years after diagnosis this was 11% in Group A, 28% in Group B, and 45% in Group C (p=0.001) and the median time to start of thiopurines was 77, 21 and 11 months in Group A, B and C respectively. There was a significant reduction in long-term steroid use at 5 years post diagnosis: 45 (44%), 31 (31%) and 24 (19%) patients in Group A, B and C respectively (p=0.001). KM analysis showed a significant reduction in the cumulative probability of intestinal surgery: At 5 years this was 59% (Group A), 37% (Group B) and 25% (Group C) (p=0.001). In a multivariate Cox analysis, year of diagnosis, disease location, oral corticosteroids within 3 months of diagnosis and early thiopurine use (within the first year of diagnosis) were all independent factors affecting likelihood of intestinal surgery.

CONCLUSION:

This population-based cohort shows marked changes in rates of surgery, and the reduction is independently associated with year of diagnosis, and associated temporally with increased and earlier thiopurine use.



Related Articles
Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery.
Gut. 2005
Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery.
Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Gut. 2005 Feb; 54(2):237-41.
[The effect of early immunosuppressive therapy on the rate of resections performed in patients with Chron's disease, in Veszprém county, Hungary, a population-based cohort study].
Orv Hetil. 2012
[The effect of early immunosuppressive therapy on the rate of resections performed in patients with Chron's disease, in Veszprém county, Hungary, a population-based cohort study].
Golovics PA, Lakatos PL, Dávid G, Pandur T, Erdélyi Z, Horváth A, Mester G, Balogh M, Szipocs I, Molnár C, et al. Orv Hetil. 2012 Apr 8; 153(14):541-52.
Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen.
Dig Liver Dis. 2009
Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen.
Latella G, Cocco A, Angelucci E, Viscido A, Bacci S, Necozione S, Caprilli R. Dig Liver Dis. 2009 Apr; 41(4):269-76. Epub 2008 Oct 26.
Review Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Cochrane Database Syst Rev. 2009
Review Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Prefontaine E, Macdonald JK, Sutherland LR. Cochrane Database Syst Rev. 2009 Oct 7; (4):CD000545. Epub 2009 Oct 7.
Review Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
Cochrane Database Syst Rev. 2009
Review Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
Prefontaine E, Sutherland LR, Macdonald JK, Cepoiu M. Cochrane Database Syst Rev. 2009 Jan 21; (1):CD000067. Epub 2009 Jan 21.
Histopathological changes in anatomical distribution of inflammatory bowel disease in children: a retrospective cohort study.
BMC Pediatr. 2012
Histopathological changes in anatomical distribution of inflammatory bowel disease in children: a retrospective cohort study.
Tsang J, Sikora S, Spady D, El-Matary W. BMC Pediatr. 2012 Oct 13; 12:162. Epub 2012 Oct 13.
Review Surgery for Crohn's disease in the era of biologicals: a reduced need or delayed verdict?
World J Gastroenterol. 2012
Review Surgery for Crohn's disease in the era of biologicals: a reduced need or delayed verdict?
de Buck van Overstraeten A, Wolthuis A, D'Hoore A. World J Gastroenterol. 2012 Aug 7; 18(29):3828-32.
Review Impact of medical therapies on inflammatory bowel disease complication rate.
World J Gastroenterol. 2012
Review Impact of medical therapies on inflammatory bowel disease complication rate.
Reenaers C, Belaiche J, Louis E. World J Gastroenterol. 2012 Aug 7; 18(29):3823-7.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.